District of Columbia, District of Columbia Clinical Trials

A listing of District of Columbia, District of Columbia clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 95 clinical trials
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry

The ICGG Gaucher Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Gaucher disease, irrespective of treatment status. No experimental intervention is involved; patients in the Registry undergo clinical assessments and receive care as determined by the patient's treating physician. The …

deficiency
imiglucerase
eliglustat
gaucher disease
Investigational Site Number 840067
 (1.9 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +220 other locations
Mucopolysaccharidosis I (MPS I) Registry

The Mucopolysaccharidosis I (MPS I) Registry is an ongoing, observational database that tracks the outcomes of patients with MPS I. The data collected by the MPS I Registry will provide information to better characterize the natural history and progression of MPS I as well as the clinical responses of patients …

Investigational Site Number 840067
 (1.9 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +135 other locations
Pompe Disease Registry

The Pompe Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Pompe disease, irrespective of treatment status. No experimental intervention is involved; patients in the Registry undergo clinical assessments and receive care as determined by the patient's treating physician. The objectives …

replacement therapy
glycogen storage disease type ii
gaa gene
deficiency
myozyme
Investigational Site Number 840067
 (1.9 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +190 other locations
Fabry Disease Registry & Pregnancy Sub-registry

The Fabry Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Fabry disease, irrespective of treatment status. No experimental intervention is involved; patients in the Registry undergo clinical assessments and receive care as determined by the patient's treating physician. The primary …

agalsidase beta
replacement therapy
fabry's disease
deficiency
fabrazyme
Investigational Site Number 840067
 (1.9 away) Contact site
  • 0 views
  • 05 Aug, 2024
  • +136 other locations
A Longitudinal Study of COVID-19 Sequelae and Immunity

Background COVID-19 is a disease caused by the SARS-CoV-2 virus. It infects the respiratory tract. Some people who get COVID-19 have only mild symptoms. But for others, infection leads to pneumonia, respiratory failure, and, in some cases, death. Researchers want to learn more about any effects that may persist after …

pneumonia
pediatric
nasopharyngeal swab
antibody test
fever
National Institutes of Health Clinical Center
 (7.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
Proton Radiation Therapy Registry

The Johns Hopkins Proton Therapy center is establishing a registry to capture the full 3D radiation dosimetry delivered to the patient, baseline clinical data, and disease, toxicity and quality of life outcomes. The goal is to have all patients treated at the proton center to be included in the registry …

Sibley Memorial Hospital
 (3.9 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +3 other locations
Saliva as Source of Detection for SARS-CoV-2

Background Nasopharyngeal (NP) swabbing is being used to test for SARS-CoV-2 infection. For this, a swab is inserted deep into the back of the nose to collect a sample. It can cause discomfort for most people. Researchers want to find an easier way to collect samples. Objective To learn if …

SARS
nasopharyngeal swab
discomfort
acute respiratory syndrome (sars)
nasal swab
National Institutes of Health Clinical Center
 (7.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
Surveillance of Individuals Following SARS-CoV-2 Exposure

Background People who have had contact with a person with a known SARS-CoV-2 infection are being told to self-quarantine for 14 days. This is done to avoid potential virus spread. But the actual time it takes for a person to develop an infection after being exposed to the virus is …

SARS
covid-19
acute respiratory syndrome (sars)
National Institutes of Health Clinical Center
 (7.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
Barriers to Screening Breast MRI Utilization Among Patients at Elevated Risk

This study seeks to develop an explanatory framework for breast MRI utilization to inform future interventions. The Health Services Utilization Model (HSUM) will guide the selection of specific participant-level factors for examination, including predisposing characteristics (knowledge, health/cultural beliefs), enabling resources (social support, cost/insurance coverage), and perceived need (perceived susceptibility, provider …

BRCA1/2
magnetic resonance imaging of breast
screening mammography
BRCA1
mammogram
Georgetown Lombardi Comprehensive Cancer Center
 (2.7 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +1 other locations
Sample Collection for Systems Evaluation of Patients With Unknown or Incompletely Characterized Immune Defects

Background The immune system defends the body against disease. It has many different parts spread out in the body, including in the blood and skin. To learn more about it, researchers want to study samples from people with healthy immune systems and people with conditions that affect how the immune …

autoimmune disease
gastrointestinal symptoms
dermatitis
episodic fever
endoscopies
National Institutes of Health Clinical Center
 (7.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location